Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
Felbamate block of the N-methyl-D-aspartate receptorS Subramaniam, J M Rho, L Penix, et al.The Journal of Rheumatology|March 1, 1993
A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritisD H Trock, A J Bollet, R H Dyer, et al.Clinical Radiology|June 12, 2014
N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?K G Foley, W G Lewis, P Fielding, et al.Cancer Research|August 17, 2000
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomasG Xinarianos, T Liloglou, W Prime, et al.Clinical Radiology|September 18, 2012
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancerD S Y Chan, P Fielding, S A Roberts, et al.The Journal of Surgical Research|January 1, 1995
PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileumJ A Quin, S A Sgambati, J R Goldenring, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2018
Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancerN Patel, Kieran G Foley, A G Powell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimensJ R Dunn, J Garde, K Dolan, et al.The American Journal of Physiology|May 1, 1993
Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colonG H Ballantyne, J R Goldenring, F X Fleming, et al.Archives of Pathology & Laboratory Medicine|July 11, 2000
College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference ParticipantsM E Hammond, P L Fitzgibbons, C C Compton, et al.Pageof 8